(2017) Intralesional bevacizumab (Avastin (R)) as a novel addition to infantile hemangioma management: A medical hypothesis. Journal of Research in Pharmacy Practice. pp. 190-191. ISSN 2319-9644
Full text not available from this repository.
Official URL: http://apps.webofknowledge.com/InboundService.do?F...
| Item Type: | Article |
|---|---|
| Keywords: | proliferative diabetic-retinopathy growth-factor therapy intravitreal bevacizumab capillary hemangioma angiogenesis inhibitor |
| Divisions: | Faculty of Dental > Department of Endodontics Faculty of Medicine > Departments of Clinical Sciences > Department of Eye |
| Page Range: | pp. 190-191 |
| Journal or Publication Title: | Journal of Research in Pharmacy Practice |
| Journal Index: | ISI |
| Volume: | 6 |
| Number: | 3 |
| Identification Number: | https://doi.org/10.4103/jrpp.JRPP₁₇₃₈ |
| ISSN: | 2319-9644 |
| Depositing User: | مهندس مهدی شریفی |
| URI: | http://eprints.mui.ac.ir/id/eprint/418 |
Actions (login required)
 |
View Item |